OS Therapies Inc
OSTXFigures shown here come from public SEC filings. Dates beside each section show the available history.
How OS Therapies Inc Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 3 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated May 15, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| STIFEL FINANCIAL CORP | 2026-03-31 | 15,000 | Not shown | SEC filing |
| Beacon Pointe Advisors, LLC | 2026-03-31 | 62,507 | Not shown | SEC filing |
| TWO SIGMA INVESTMENTS, LP | 2026-03-31 | 26,380 | Not shown | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 280,045 | Not shown | SEC filing |
| FMR LLC | 2026-03-31 | 2 | Not shown | SEC filing |
| CM Management, LLC | 2026-03-31 | 400,000 | Not shown | SEC filing |
| BlackRock, Inc. | 2026-03-31 | 64,772 | Not shown | SEC filing |
| UBS Group AG | 2026-03-31 | 348,678 | Not shown | SEC filing |
| STATE STREET CORP | 2026-03-31 | 91,200 | Not shown | SEC filing |
| MORGAN STANLEY | 2026-03-31 | 9,490 | Not shown | SEC filing |
| HighTower Advisors, LLC | 2026-03-31 | 15,200 | Not shown | SEC filing |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 2026-03-31 | 25,000 | Not shown | SEC filing |
| Caitong International Asset Management Co., Ltd | 2026-03-31 | 17 | Not shown | SEC filing |
| Tower Research Capital LLC (TRC) | 2026-03-31 | 4,179 | Not shown | SEC filing |
| Stratos Wealth Advisors, LLC | 2026-03-31 | 13,817 | Not shown | SEC filing |
| JONES FINANCIAL COMPANIES LLLP | 2026-03-31 | 12,921 | Not shown | SEC filing |
| MERCER GLOBAL ADVISORS INC /ADV | 2026-03-31 | 10,220 | Not shown | SEC filing |
| SANDERS MORRIS HARRIS LLC | 2026-03-31 | 32,000 | Not shown | SEC filing |
| XTX Topco Ltd | 2026-03-31 | 31,622 | Not shown | SEC filing |
| JANE STREET GROUP, LLC | 2026-03-31 | 40,316 | Not shown | SEC filing |
- Each value is checked against OS Therapies Inc's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- LPL Financial LLC: 10,113 shares reported 2025-12-31; 10,113 shares reported 2026-03-31.
- ARMSTRONG ADVISORY GROUP, INC: 100 shares reported 2025-12-31; 100 shares reported 2026-03-31.
- NORTHERN TRUST CORP: 71,309 shares reported 2025-12-31; 66,054 shares reported 2026-03-31.
- INGALLS & SNYDER LLC: 36,676 shares reported 2025-12-31; 36,676 shares reported 2026-03-31.
- SUSQUEHANNA INTERNATIONAL GROUP, LLP: 14,961 shares reported 2025-09-30; 448,737 shares reported 2026-03-31.
- JANE STREET GROUP, LLC: 27,740 shares reported 2025-12-31; 40,316 shares reported 2026-03-31.
- XTX Topco Ltd: 33,489 shares reported 2025-06-30; 31,622 shares reported 2026-03-31.
- SANDERS MORRIS HARRIS LLC: 12,000 shares reported 2025-09-30; 32,000 shares reported 2026-03-31.
- MERCER GLOBAL ADVISORS INC /ADV: 10,220 shares reported 2025-12-31; 10,220 shares reported 2026-03-31.
- JONES FINANCIAL COMPANIES LLLP: 10,867 shares reported 2025-12-31; 12,921 shares reported 2026-03-31.
- Stratos Wealth Advisors, LLC: 13,817 shares reported 2025-12-31; 13,817 shares reported 2026-03-31.
- Tower Research Capital LLC (TRC): 88 shares reported 2025-12-31; 4,179 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
13 filers have only one report here.
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2025-05-07 | Auerbach Shalom · 10% owner | Common Stock, par value $0.001 per share | S — Open market or private sale | −82,000 | 2.00 | SEC filing |
| 2025-04-10 | Auerbach Shalom · 10% owner | Common Stock, par value $0.001 per share | S — Open market or private sale | −10,000 | 1.39 | SEC filing |
| 2025-04-09 | Auerbach Shalom · 10% owner | Common Stock, par value $0.001 per share | S — Open market or private sale | −50,012 | 1.35 | SEC filing |
| 2025-02-14 | Auerbach Shalom · 10% owner | Common Stock, par value $0.001 per share | S — Open market or private sale | −100,000 | 2.84 | SEC filing |
| 2025-01-15 | Auerbach Shalom · 10% owner | Common Stock, par value $0.001 per share | S — Open market or private sale | −16,720 | 6.74 | SEC filing |
Showing 5 of 5 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-01-22 | Search Theodore F. · Director | Stock options (right to buy) | A — Grant, award, or other acquisition | +50,000 | SEC filing |
| 2026-01-22 | Galzahr Karim · Director | Stock options (right to buy) | A — Grant, award, or other acquisition | +50,000 | SEC filing |
| 2026-01-22 | Acevedo Christopher P. · Chief Financial Officer | Stock options (right to buy) | A — Grant, award, or other acquisition | +100,000 | SEC filing |
| 2026-01-22 | Ciccio John · Director | Stock options (right to buy) | A — Grant, award, or other acquisition | +50,000 | SEC filing |
| 2026-01-22 | McKean-Dieser Avril Suzette · Director | Stock options (right to buy) | A — Grant, award, or other acquisition | +50,000 | SEC filing |
| 2026-01-22 | Jarry Olivier Roger · Director | Stock options (right to buy) | A — Grant, award, or other acquisition | +50,000 | SEC filing |
| 2026-01-22 | Romness Paul A. · President and CEO | Stock options (right to buy) | A — Grant, award, or other acquisition | +1,000,000 | SEC filing |
| 2026-01-22 | PETIT ROBERT · See Remarks | Stock options (right to buy) | A — Grant, award, or other acquisition | +100,000 | SEC filing |
Showing 8 of 20 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2025-02-28 | Romness Paul A. · President and CEO | Common Stock, par value $0.001 per share | J — Other acquisition or disposition | +225,000 | SEC filing |
| 2025-02-27 | Auerbach Shalom · 10% owner | Common Stock, par value $0.001 per share | J — Other acquisition or disposition | −225,000 | SEC filing |
Showing 2 of 2 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.